Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries
Omnipulse Biosciences has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.
Omnipulse Biosciences's investors include Trousdale Ventures, Kendall Capital Partners.
Omnipulse Biosciences is headquartered in Cambridge, United States.
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries
Omnipulse Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Omnipulse Biosciences — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/omnipulse-biosciences. Accessed November 13, 2026.
VCBacked. (2023). Omnipulse Biosciences — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/omnipulse-biosciences
{{cite web |title=Omnipulse Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/omnipulse-biosciences |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Omnipulse Biosciences? Request a listing update